There is controversy regarding the use of Lp(a) in the prevention of atherosclerotic cardiovascular disease (ASCVD); more than 90% of circulating Lp(a) levels are genetically determined, not greatly influenced by diet or behavioral measures. Here, LPA is linked to atherosclerosis.